Cancer Genomics and Immunogenomics
The lab develops and applies computational tools to study DNA and RNA aberrations that drive cancer and how these produce novel therapeutic opportunities. The lab uses bioinformatics and machine learning methods to characterize alterations in cancer cells and advance precision medicine for cancer patients. Our expertise can be applied to any tumor type, but we have special interest in cancers arising from immune cells and specifically chronic lymphocytic leukemia (CLL), a common B-cell leukemia. Thus, on the intersection of cancer genomics and immunology, we study the relationship between cancerous and normal immune cells and use computational genomics to identify new targets for immunotherapy.
The lab is launching in October 2022! We are recruiting highly motivated individuals for all training stages – MSc, PhD and Postdocs. MDs or individuals from other fields with programming experience that are enthusiastic about bioinformatics are welcome to apply.